Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients

Breast Cancer

Volumn 5, Issue 4, 1998, Pages 381-387

  Noguchi, Masakuni ^a   Tsugawa, Koichiro ^a   Kawahara, Futoshi ^a   Bando, Etsuro ^a   Miwa, Koichi ^a   Minato, Hiroshi ^a   Nonomura, Akitaka ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Breast cancer; Sentinel lymph node

Indexed keywords

EID: 0000578158     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967435     Document Type: Article

References (35)

1. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-61, 1985.
2. Lythgoe JP, Palmer MK: Manchester regional breast study; 5 and 10 years results. Br J Surg 69:693-696, 1982. (Pubitemid 13201853)
3. Cancer Research Campaign Work Party: Cancer Research Campaign (King's Cambridge) trial for early breast cancer. Lancet 2:55-60, 1980.
4. Hayward JL: The Guy's trial of treatment of 'early breast cancer'. World J Surg 1:314-316, 1997.
5. Cabanes PA, Salmon RJ, Vilcoq IR, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339:1245-1248, 1992.
6. Senofsky GM, Moffat FL Jr, Davis K, et al: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126:1336-1342, 1991.
7. Donegan WL: Surgical clinical trials. Cancer 53:691-699, 1984. (Pubitemid 14190894)
8. Fentiman IS, Mansel RE: The axilla; Not a no-go zone. Lancet 337:221-223, 1991.
9. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphedema following the treatment of breast cancer. Br J Surg 73:580-585, 1986.
10. Wazer DE, Erban JK, Robert NJ, et al: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 74:878-883, 1994. (Pubitemid 24237468)
11. Feigelson BJ, Acosta JA, Feigelson HS, et al: T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am J Surg 172:487-490, 1996. (Pubitemid 26415757)
12. Silverstein MJ, Gierson ED, Waisman JR, et al: Axillary lymph node dissection for Tla breast carcinoma; Is it indicated? Cancer 73:664-667, 1994. (Pubitemid 24046609)
13. Cady B: The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 73:505-508, 1994. (Pubitemid 24046585)
14. Chadha M, Chabon AB, Friedmann P, et al: Predictors of axillary lymph node metastases in patients with Tl breast cancer. Cancer 73:350-353, 1994. (Pubitemid 24030613)
15. Greco M, Agresti R, Raselli R, et al: Axillary dissection can be avoided in selected breast cancer patients; Analysis of 401 cases. Anticancer Res 16:3913-3918, 1996. (Pubitemid 127663740)
16. Noguchi M, Katev N, Miyazaki I: Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 40:283-293, 1996. (Pubitemid 26336124)
17. Noguchi M, Miwa K, Michigishi T, et al: The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4:143-153, 1997.
18. Noguchi M, Kawahara F, Tsugawa K, et al: Sentinel lymphadenectomy in breast cancer; Alternative to routine axillary dissection. Breast Cancer 5:1-7, 1998.
19. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994. (Pubitemid 24313232)
20. Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma; An alternative to routine axillary dissection. J Surg Oncol 62 (2):75-77, 1996. (Pubitemid 26196502)
21. Albertini JA, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996.
22. Veronesi U, Paganelli G, Galimberti V, et al: Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-node. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
23. Krag DN, Weaver DL, Alex C, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
24. Pijpers R, Meijer S, Hoekstra OS, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368, 1997. (Pubitemid 27376884)
25. Turner RR, Ollila DW, Krasne DL, et al: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-278, 1997. (Pubitemid 28070919)
26. Japan Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed, Kanehara, Tokyo, pp 19-34, 1996.
27. The World Health Organization: The World Health Organization histological typing of breast tumors. Am J Clin Pathol 78:806-816, 1982.
28. Alazraki N: Lymphoscintigraphy and the intraoperrative gamma probe. J Nucl Med 36:1780-1783, 1995.
29. Uren RF, Howman-Giles RB, Thompson JF, et al: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775-1780, 1995.
30. Giuliano AE, Dale PS, Turner RB, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995.
31. Giuliano AE: Sentinel lymphadenectomy; A new axillary staging procedure for primary breast carcinoma. Breast Dis 7:16-17, 1996.
32. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 81:1615-1616, 1994. (Pubitemid 24349934)
33. Fisher CJ, Boyle S, Burke M, et al: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458, 1993. (Pubitemid 23116082)
34. Gulec SA, Moffat FL, Carroll RG, et al: Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med 41:251-261, 1997. (Pubitemid 27346872)
35. Kramer EL: Lymphoscintigraphy; Radiopharmaceutical selection and methods. Nucl Med Biol 17:57-63, 1990.